Activation of the Monocyte/Macrophage System and Abnormal Blood Levels of Lymphocyte Subpopulations in Individuals with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
暂无分享,去创建一个
J. Ramos-Quiroga | R. Pujol-Borrell | M. Martínez-Gallo | G. Arteaga-Henríquez | J. Lugo-Marín | L. Gisbert | Imanol Setién-Ramos
[1] M. Simone,et al. B and T Immunoregulation: A New Insight of B Regulatory Lymphocytes in Autism Spectrum Disorder , 2021, Frontiers in Neuroscience.
[2] Guohua Li,et al. Risk of Self-harm in Children and Adults With Autism Spectrum Disorder , 2021, JAMA network open.
[3] A. Tufan,et al. Evaluation of peripheral inflammatory markers, serum B12, folate, ferritin levels and clinical correlations in children with autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) , 2021, Nordic journal of psychiatry.
[4] B. Aouizerate,et al. Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlates , 2021, Brain, Behavior, and Immunity.
[5] M. Alpay,et al. The systemic cell apoptotic-based neutrophil–lymphocyte ratio: Experience in children diagnosed with ADHD and Autism Spectrum Disorder , 2020, Konuralp Tıp Dergisi.
[6] M. Ceylan,et al. Serum Ischemia-Modified Albumin Levels, Myeloperoxidase Activity and Peripheral Blood Mononuclear cells in Autism Spectrum Disorder (ASD) , 2020, Journal of Autism and Developmental Disorders.
[7] C. Nemeroff,et al. The Bidirectional Relationship of Depression and Inflammation: Double Trouble , 2020, Neuron.
[8] M. Shehata,et al. Thioredoxin level and inflammatory markers in children with autism spectrum disorders , 2020, Middle East Current Psychiatry.
[9] P. Ashwood,et al. T cell populations in children with autism spectrum disorder and co-morbid gastrointestinal symptoms. , 2020, Brain, behavior, & immunity - health.
[10] Mai Moaaz,et al. Th17/Treg cells imbalance and their related cytokines (IL-17, IL-10 and TGF-β) in children with autism spectrum disorder , 2019, Journal of Neuroimmunology.
[11] Matthew P. Anderson,et al. T lymphocytes and cytotoxic astrocyte blebs correlate across autism brains , 2019, Annals of neurology.
[12] N. Rezaei,et al. Anti-inflammatory cytokines in autism spectrum disorders: A systematic review and meta-analysis. , 2019, Cytokine.
[13] R. Frye,et al. Inheritance of HLA-Cw7 Associated With Autism Spectrum Disorder (ASD) , 2019, Front. Psychiatry.
[14] N. Rezaei,et al. A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude. , 2019, Journal of psychiatric research.
[15] S. Wueest,et al. The role of adipocyte-specific IL-6-type cytokine signaling in FFA and leptin release , 2018, Adipocyte.
[16] R. Delorme,et al. HLA-class II haplotypes and Autism Spectrum Disorders , 2018, Scientific reports.
[17] B. H. Lo,et al. Autism Spectrum Disorder , 2018, Journal of paediatrics and child health.
[18] M. Zaki,et al. Altered Adaptive Cellular Immune Function in a Group of Egyptian Children with Autism , 2017 .
[19] M. Ceylan,et al. High monocyte level and low lymphocyte to monocyte ratio in autism spectrum disorders , 2017, International journal of developmental disabilities.
[20] I. Frazer,et al. Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity , 2017, Cell Death & Disease.
[21] E. Courchesne,et al. Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder , 2017, Molecular Psychiatry.
[22] F. Shebl,et al. Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study , 2017, Molecular Autism.
[23] A. Nadeem,et al. Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism , 2016, Molecular Neurobiology.
[24] M. Posada,et al. Characterization of immune cell phenotypes in adults with autism spectrum disorders , 2016, Journal of Investigative Medicine.
[25] E. Bosmans,et al. Decreased Numbers of CD57+CD3- Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder. , 2016, In vivo.
[26] C. Tufanaru,et al. Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness , 2015, International journal of evidence-based healthcare.
[27] L. Barcellos,et al. Immune mediated conditions in autism spectrum disorders , 2015, Brain, Behavior, and Immunity.
[28] Jin-gang Fan,et al. High plasma neopterin levels in Chinese children with autism spectrum disorders , 2015, International Journal of Developmental Neuroscience.
[29] N. Kounis,et al. White Blood Cell Counts, Leukocyte Ratios, and Eosinophils as Inflammatory Markers in Patients With Coronary Artery Disease , 2015, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[30] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.
[31] A. Guastella,et al. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis , 2014, Molecular Psychiatry.
[32] I. Hertz-Picciotto,et al. Maternal lifestyle and environmental risk factors for autism spectrum disorders. , 2014, International journal of epidemiology.
[33] M. Ceylan,et al. Serum neopterin levels in patients with autism , 2014 .
[34] P. Ashwood,et al. Decreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction , 2012, Journal of Neuroimmunology.
[35] Jolanta Wasilewska,et al. Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old , 2012, Archives of medical science : AMS.
[36] T. Wilt,et al. Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program. , 2011, Journal of clinical epidemiology.
[37] F. Shi,et al. Organ-specific features of natural killer cells , 2011, Nature Reviews Immunology.
[38] D. Amaral,et al. In Search of Cellular Immunophenotypes in the Blood of Children with Autism , 2011, PloS one.
[39] E. Courchesne,et al. Microglial Activation and Increased Microglial Density Observed in the Dorsolateral Prefrontal Cortex in Autism , 2010, Biological Psychiatry.
[40] P. Ashwood,et al. Immune dysfunction in autism: A pathway to treatment , 2010, Neurotherapeutics.
[41] G. Mostafa,et al. Frequency of CD4+CD25high Regulatory T Cells in the Peripheral Blood of Egyptian Children With Autism , 2010, Journal of child neurology.
[42] R. Drexhage,et al. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder , 2010, Expert review of neurotherapeutics.
[43] Paula Krakowiak,et al. Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders , 2009, Journal of Neuroimmunology.
[44] C. Tinelli,et al. An Autistic Endophenotype Results in Complex Immune Dysfunction in Healthy Siblings of Autistic Children , 2009, Biological Psychiatry.
[45] J. Carcillo,et al. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[46] J. Gregg,et al. Altered gene expression and function of peripheral blood natural killer cells in children with autism , 2009, Brain, Behavior, and Immunity.
[47] Jaquelyn B. McCandless,et al. Low natural killer cell cytotoxic activity in autism: The role of glutathione, IL-2 and IL-15 , 2008, Journal of Neuroimmunology.
[48] David Moher,et al. Addressing Reporting Biases , 2008 .
[49] A. Zimmerman,et al. Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.
[50] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[51] C. McDougle,et al. High blood monocyte counts and neopterin levels in children with autistic disorder. , 2003, The American journal of psychiatry.
[52] D. Fuchs,et al. Neopterin as a marker for immune system activation. , 2002, Current drug metabolism.
[53] K. Żwirska-Korczala,et al. Neopterin measurement in clinical diagnosis , 2001, Journal of clinical pharmacy and therapeutics.
[54] R. Warren,et al. Reduced natural killer cell activity in autism. , 1987, Journal of the American Academy of Child and Adolescent Psychiatry.
[55] A. Kutlu,et al. Does increased neutrophil-lymphocyte ratio predict autism spectrum disorder? , 2018 .
[56] I. Tonhajzerova,et al. Inflammatory Activity in Autism Spectrum Disorder. , 2015, Advances in experimental medicine and biology.
[57] J. Higgins. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .
[58] Karen Shashok,et al. BMC Medical Research Methodology BioMed Central Debate Conducting a meta-ethnography of qualitative literature: Lessons learnt , 2008 .
[59] C. Tirolo,et al. Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. , 1996, Annali dell'Istituto superiore di sanita.